Randomized study of intravenous versus subcutaneous interleukin-2, and IFNalpha in patients with good prognosis metastatic renal cancer. [electronic resource]
Producer: 20081008Description: 5907-12 p. digitalISSN:- 1078-0432
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Renal Cell -- drug therapy
- Disease-Free Survival
- Drug Administration Schedule
- Female
- Humans
- Injections, Intravenous
- Injections, Subcutaneous
- Interferon-alpha -- administration & dosage
- Interleukin-2 -- administration & dosage
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Metastasis
- Prognosis
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.